Apipharma is recalling approximately 9,313 units of Hemopropin Ointment and Kapsin Ointment due to Current Good Manufacturing Practice (CGMP) deviations. Hemopropin Ointment (used for skin protection) and Kapsin Ointment (a topical analgesic) were manufactured in Croatia and distributed in Arizona. The recall involves specific lot numbers of 20g and 60g tubes with expiration dates between 2025 and 2028.
The ointments were manufactured under conditions that did not meet quality and safety standards, meaning the purity and safety of the products cannot be guaranteed. Using drugs that deviate from manufacturing standards can lead to ineffective treatment or potential exposure to contaminants.
You have 2 options:
Manufactured by Apipharma d.o.o, Croatia; Distributed by Apipharma, LLC, Tempe, AZ
Manufactured by Apipharma d.o.o, Croatia; Distributed by Apipharma, LLC, Tempe, AZ
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.